| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &Chief Financial Officer
1 company
Astle Christopher is a SVP &Chief Financial Officer at Zymeworks Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $160K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | ZYME Zymeworks Inc. | SVP &Chief Financial Officer | Sale+OE | 5,994 | $10.79 | $64,655.51 | -29.3% | -16.6% | +24.0% | |
| Dec 11, 2023 | ZYME Zymeworks Inc. | SVP &Chief Financial Officer | Sale+OE | 886 | $9.13 | $8,089.27 | -30.7% | +19.8% | +41.6% | |
| Dec 12, 2022 | ZYME Zymeworks Inc. | SVP &Chief Financial Officer | Sale+OE | 887 | $6.01 | $5,330.87 | -40.0% | +37.5% | +53.2% |